SV2011004056A - Respuesta inmunitaria reforzada en especies aviares - Google Patents
Respuesta inmunitaria reforzada en especies aviaresInfo
- Publication number
- SV2011004056A SV2011004056A SV2011004056A SV2011004056A SV2011004056A SV 2011004056 A SV2011004056 A SV 2011004056A SV 2011004056 A SV2011004056 A SV 2011004056A SV 2011004056 A SV2011004056 A SV 2011004056A SV 2011004056 A SV2011004056 A SV 2011004056A
- Authority
- SV
- El Salvador
- Prior art keywords
- immune response
- avian species
- species
- reinforced
- aviary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
UN PROCEDIMIENTO DE ACTIVACIÓN INMUNITARIA QUE ES EFICAZ PARA PROVOCAR UNA RESPUESTA INMUNITARIA NO ESPECÍFICA DE ANTÍGENO EN UN MIEMBRO DE LAS ESPECIES AVIARES. EL PROCEDIMIENTO ES PARTICULARMENTE EFICAZ PARA PROTEGER A UN MIEMBRO DE LAS ESPECIES AVIARES DE ENFERMEDAD INFECCIOSA Y PARA TRATAR ANIMALES AFECTADOS CON ENFERMEDAD INFECCIOSA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17809909P | 2009-05-14 | 2009-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2011004056A true SV2011004056A (es) | 2012-03-14 |
Family
ID=42357738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2011004056A SV2011004056A (es) | 2009-05-14 | 2011-11-10 | Respuesta inmunitaria reforzada en especies aviares |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US20120064151A1 (es) |
| EP (2) | EP2429581B1 (es) |
| JP (1) | JP5679589B2 (es) |
| KR (2) | KR20170102379A (es) |
| CN (2) | CN102427827B (es) |
| AR (1) | AR076767A1 (es) |
| AU (1) | AU2010246652B2 (es) |
| BR (1) | BRPI1010803A2 (es) |
| CA (1) | CA2761736C (es) |
| CL (1) | CL2011002808A1 (es) |
| CO (1) | CO6460752A2 (es) |
| CR (1) | CR20110595A (es) |
| DK (2) | DK2429581T3 (es) |
| EC (1) | ECSP11011448A (es) |
| ES (2) | ES2550181T3 (es) |
| HK (1) | HK1168032A1 (es) |
| HR (2) | HRP20151117T1 (es) |
| HU (2) | HUE025765T2 (es) |
| IL (1) | IL215900A (es) |
| LT (1) | LT2992899T (es) |
| MX (1) | MX336019B (es) |
| MY (1) | MY162561A (es) |
| NI (1) | NI201100196A (es) |
| NZ (1) | NZ596366A (es) |
| PE (1) | PE20120903A1 (es) |
| PL (2) | PL2992899T3 (es) |
| PT (2) | PT2429581E (es) |
| RU (1) | RU2570732C9 (es) |
| SI (2) | SI2992899T1 (es) |
| SV (1) | SV2011004056A (es) |
| TW (1) | TWI555846B (es) |
| UA (1) | UA106076C2 (es) |
| UY (1) | UY32634A (es) |
| WO (1) | WO2010130374A1 (es) |
| ZA (1) | ZA201107827B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009120811A1 (en) * | 2008-03-25 | 2009-10-01 | Juvaris Biotherapeutics, Inc. | Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc) |
| TR201906323T4 (tr) | 2010-12-22 | 2019-05-21 | Bayer Ip Gmbh | Sığır türlerinde artırılmış bağışıklık yanıtı. |
| JO3733B1 (ar) | 2011-04-05 | 2021-01-31 | Bayer Ip Gmbh | استخدام 3,2-دايهيدروايميدازو[1, 2 -c]كوينازولينات مستبدلة |
| CN103721253B (zh) * | 2014-01-02 | 2015-06-10 | 青岛易邦生物工程有限公司 | 一种禽脑脊髓炎和鸡痘二联活疫苗 |
| US10155950B2 (en) * | 2014-02-28 | 2018-12-18 | Bayer Animal Health Gmbh | Immunostimulatory plasmids |
| US9814769B2 (en) | 2014-09-30 | 2017-11-14 | Qatar University | Vaccines against pathogenic Escherichia coli and methods of using the same |
| PE20181208A1 (es) * | 2015-06-26 | 2018-07-23 | Bayer Animal Health Gmbh | Metodos de modulacion de moleculas de vigilancia de adn citosolicas |
| DK3328423T3 (da) * | 2015-07-31 | 2021-07-26 | Bayer Animal Health Gmbh | Forbedret immunrespons hos fisk |
| AU2016302436B2 (en) * | 2015-07-31 | 2022-03-03 | Bayer Animal Health Gmbh | Enhanced immune response in porcine species |
| EP3490598A1 (en) | 2016-07-26 | 2019-06-05 | Bayer Animal Health GmbH | Increased fertility in bovine species |
| CN111447949A (zh) * | 2017-12-15 | 2020-07-24 | 拜耳动物保健有限责任公司 | 免疫刺激寡核苷酸 |
| CN114467855A (zh) * | 2022-01-14 | 2022-05-13 | 广东海大集团股份有限公司 | 一种多病因气囊炎雏鸡模型的构建方法及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4458630A (en) * | 1982-06-22 | 1984-07-10 | The United States Of America As Represented By The Secretary Of Agriculture | Disease control in avian species by embryonal vaccination |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5427791A (en) | 1992-08-05 | 1995-06-27 | Regents Of The University Of Minnesota | Embryonal vaccine against Newcastle disease |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US6048535A (en) | 1997-06-12 | 2000-04-11 | Regents Of The University Of Minnesota | Multivalent in ovo avian vaccine |
| US6693086B1 (en) | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| DK1459766T3 (da) * | 1999-03-26 | 2008-10-13 | Vical Inc | Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner |
| WO2001048018A1 (en) * | 1999-12-27 | 2001-07-05 | University Of Manitoba | Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens |
| US20050181035A1 (en) * | 2004-02-17 | 2005-08-18 | Dow Steven W. | Systemic immune activation method using non CpG nucleic acids |
| WO2009120811A1 (en) * | 2008-03-25 | 2009-10-01 | Juvaris Biotherapeutics, Inc. | Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc) |
-
2010
- 2010-05-07 SI SI201032031T patent/SI2992899T1/sl unknown
- 2010-05-07 RU RU2011150529/15A patent/RU2570732C9/ru active
- 2010-05-07 LT LTEP15178476.6T patent/LT2992899T/lt unknown
- 2010-05-07 ES ES10720350.7T patent/ES2550181T3/es active Active
- 2010-05-07 KR KR1020177024103A patent/KR20170102379A/ko not_active Application Discontinuation
- 2010-05-07 AU AU2010246652A patent/AU2010246652B2/en active Active
- 2010-05-07 CN CN201080021073.9A patent/CN102427827B/zh active Active
- 2010-05-07 BR BRPI1010803-3A patent/BRPI1010803A2/pt not_active Application Discontinuation
- 2010-05-07 EP EP10720350.7A patent/EP2429581B1/en active Active
- 2010-05-07 PT PT107203507T patent/PT2429581E/pt unknown
- 2010-05-07 NZ NZ596366A patent/NZ596366A/en unknown
- 2010-05-07 PL PL15178476T patent/PL2992899T3/pl unknown
- 2010-05-07 MX MX2011011931A patent/MX336019B/es unknown
- 2010-05-07 CA CA2761736A patent/CA2761736C/en active Active
- 2010-05-07 KR KR1020117029865A patent/KR101966989B1/ko active IP Right Grant
- 2010-05-07 UA UAA201114824A patent/UA106076C2/uk unknown
- 2010-05-07 DK DK10720350.7T patent/DK2429581T3/en active
- 2010-05-07 HU HUE10720350A patent/HUE025765T2/en unknown
- 2010-05-07 DK DK15178476.6T patent/DK2992899T3/da active
- 2010-05-07 WO PCT/EP2010/002809 patent/WO2010130374A1/en active Application Filing
- 2010-05-07 SI SI201031045T patent/SI2429581T1/sl unknown
- 2010-05-07 US US13/320,289 patent/US20120064151A1/en not_active Abandoned
- 2010-05-07 PE PE2011001938A patent/PE20120903A1/es not_active Application Discontinuation
- 2010-05-07 PL PL10720350T patent/PL2429581T3/pl unknown
- 2010-05-07 ES ES15178476T patent/ES2808827T3/es active Active
- 2010-05-07 PT PT151784766T patent/PT2992899T/pt unknown
- 2010-05-07 CN CN201510317838.8A patent/CN104906573A/zh active Pending
- 2010-05-07 JP JP2012510144A patent/JP5679589B2/ja active Active
- 2010-05-07 EP EP15178476.6A patent/EP2992899B1/en active Active
- 2010-05-07 HU HUE15178476A patent/HUE051005T2/hu unknown
- 2010-05-07 MY MYPI2011005467A patent/MY162561A/en unknown
- 2010-05-12 TW TW099115052A patent/TWI555846B/zh active
- 2010-05-12 UY UY0001032634A patent/UY32634A/es not_active Application Discontinuation
- 2010-05-12 AR ARP100101647A patent/AR076767A1/es unknown
-
2011
- 2011-10-25 IL IL215900A patent/IL215900A/en active IP Right Grant
- 2011-10-26 ZA ZA2011/07827A patent/ZA201107827B/en unknown
- 2011-11-10 SV SV2011004056A patent/SV2011004056A/es unknown
- 2011-11-10 CL CL2011002808A patent/CL2011002808A1/es unknown
- 2011-11-10 EC EC2011011448A patent/ECSP11011448A/es unknown
- 2011-11-11 NI NI201100196A patent/NI201100196A/es unknown
- 2011-11-11 CO CO11153951A patent/CO6460752A2/es not_active Application Discontinuation
- 2011-11-11 CR CR20110595A patent/CR20110595A/es unknown
-
2012
- 2012-09-06 HK HK12108738.6A patent/HK1168032A1/zh unknown
-
2015
- 2015-10-22 HR HRP20151117TT patent/HRP20151117T1/hr unknown
-
2020
- 2020-09-29 HR HRP20201554TT patent/HRP20201554T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2011004056A (es) | Respuesta inmunitaria reforzada en especies aviares | |
| GT201300168A (es) | Respuesta inmune potenciada en la especie bovina | |
| CL2017001585A1 (es) | Anticuerpos anti-c5 y métodos para su uso | |
| ECSP15011603A (es) | Subunidades de vacunas de inmersión para peces | |
| CL2017002375A1 (es) | Método e instalación para criar insectos | |
| CR20150337A (es) | Derivados de pirimidinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral | |
| CL2016000358A1 (es) | Vacuna para adenovirus aviar | |
| GT201400069A (es) | Composiciones farmaceuticas | |
| CO2018001840A2 (es) | Composiciones biofarmacéuticas que comprenden anticuerpos anti-il-5 | |
| CL2012000135A1 (es) | Alimento inmunoestimulante para peces que contiene pupas de mosca o larvas de moscas. | |
| AR096660A1 (es) | Calzado para caballos | |
| MA46580A (fr) | Vecteurs de recombinaison exprimant des antigènes de virus de la grippe aviaire et utilisations associées | |
| MX2018016306A (es) | Virus de enteritis de pato y usos del mismo. | |
| CL2016001906A1 (es) | Vacunas contra el reovirus aviar. | |
| MX2018000091A (es) | Virus de la enteritis del pato y usos del mismo. | |
| BR112015012483A2 (pt) | capô de turbomáquina com a capacidade de recobrir um cone de soprador | |
| CO7230092A1 (es) | Aparato electrónico emisor de ondas electromagnéticas para ahuyentar insectos y animales en plaga | |
| NI201300058A (es) | Respuesta inmune potenciada en la especie bovina | |
| AR094459A1 (es) | Alimento procesado para mascotas | |
| TWD174231S (zh) | 人工蜂巢之組件 | |
| AR112605A1 (es) | Cepa bacillus pumilus con actividad probiótica | |
| ES1226180Y (es) | Turbina Led atrapa insectos | |
| UY34266A (es) | Métodos para aumentar el contenido de proteínas,aceites y/o aminoácidos en una planta | |
| AR100777A1 (es) | Método para mejorar la viabilidad en animales, promover el aumento de peso vivo en mamíferos y aves, mejorar la eficacia de la inmunización, y prevenir y/o tratar enfermedades infecciosas | |
| ES1156908Y (es) | Habitáculo para la cría de perdigones de granja y su adaptación al medio salvaje natural. |